- Home
- BUSE vs BCRX Comparison
BUSE vs BCRX Comparison
Compare BUSE & BCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BUSE
- BCRX
- Stock Information
- Founded
- BUSE 1868
- BCRX 1986
- Country
- BUSE United States
- BCRX United States
- Employees
- BUSE N/A
- BCRX N/A
- Industry
- BUSE Major Banks
- BCRX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BUSE Finance
- BCRX Health Care
- Exchange
- BUSE Nasdaq
- BCRX Nasdaq
- Market Cap
- BUSE 2.1B
- BCRX 1.8B
- IPO Year
- BUSE N/A
- BCRX 1994
- Fundamental
- Price
- BUSE $23.22
- BCRX $6.96
- Analyst Decision
- BUSE Buy
- BCRX Strong Buy
- Analyst Count
- BUSE 7
- BCRX 10
- Target Price
- BUSE $27.43
- BCRX $16.70
- AVG Volume (30 Days)
- BUSE 559.6K
- BCRX 3.0M
- Earning Date
- BUSE 10-28-2025
- BCRX 11-03-2025
- Dividend Yield
- BUSE 4.32%
- BCRX N/A
- EPS Growth
- BUSE N/A
- BCRX N/A
- EPS
- BUSE 1.13
- BCRX N/A
- Revenue
- BUSE $498,525,000.00
- BCRX $557,506,000.00
- Revenue This Year
- BUSE $62.58
- BCRX $41.40
- Revenue Next Year
- BUSE $11.64
- BCRX $5.33
- P/E Ratio
- BUSE $20.56
- BCRX N/A
- Revenue Growth
- BUSE 16.77
- BCRX 45.85
- 52 Week Low
- BUSE $18.40
- BCRX $6.02
- 52 Week High
- BUSE $28.30
- BCRX $11.31
- Technical
- Relative Strength Index (RSI)
- BUSE 40.20
- BCRX 24.07
- Support Level
- BUSE $22.73
- BCRX $7.24
- Resistance Level
- BUSE $23.70
- BCRX $7.47
- Average True Range (ATR)
- BUSE 0.51
- BCRX 0.21
- MACD
- BUSE -0.16
- BCRX -0.06
- Stochastic Oscillator
- BUSE 20.25
- BCRX 1.45
About BUSE First Busey Corporation
First Busey Corporation is a financial holding company, whose subsidiaries provides retail and commercial banking services, remittance processing, and offers financial products and services with banking centers in Illinois, Missouri, Florida, and Indiana. The company's operations are managed through three operating segments consisting of Banking, FirsTech and Wealth Management. The banking segment generates a vast majority of its revenue.
About BCRX BioCryst Pharmaceuticals Inc.
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.